Cure Rare Disease (CRD) announced it has been awarded a $5.69 million grant from the California Institute for Regenerative ...

Q4 2024 Earnings Call Transcript February 12, 2025 Operator: Good morning. My name is Jennifer and I will be your conference ...

In a study published in the journal Current Biology, Johns Hopkins researchers discovered that individual neurons in the ...

The recent volatility in our stock appears to be driven by misconceptions and a lack of understanding about our business and long-term strategy, but I want to reassure our investors that there have ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

At this time, I'd like to welcome everyone to the Biogen fourth-quarter and full-year 2024 earnings call and business update. [Operator instructions] Today's conference is being recorded. Thank you. I ...

Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...

In this study, we describe a multi-omics approach to uncover potential disease-causing variants in late-onset ataxia patients with episodic features lacking molecular diagnoses despite exhaustive ...

Chief Scientific Officer Yoshitsugu Shitaka, Ph.D., won’t be so lucky. Astellas intends to create the new role of chief ...

Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung diseases, today ...